Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Bavaria, D80636, Germany
Completed
NCT Number: NCT01648647
Copeptin in Aortic Valve Replacement
Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early postoperative copeptin leavens in patients undergoing different aortic valve procedures
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients undergoing surgical aortic valve replacment
- Patients undergoing transcatheter aortic valve replacment
Exclusion criteria
- denial by patient
Sponsors and collaborators
Lead sponsor
Deutsches Herzzentrum Muenchen
Other
Registry information
Official study title
GE DHM-AN-OR-2012/01
Acronym: CARE
Important dates
- Study start
- 2012
- First posted
- Jul 24, 2012
- Registry last updated
- Jul 24, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.